The signaling by IL-22 proceeds through JAK2/STAT3, which is likely to be suppressed by R9-SOCS3-KIR, making R9-SOCS3-KIR a potential candidate for the treatment of AMD. The gene discussed is SOCS3; the disease is age-related macular degeneration.